339 related articles for article (PubMed ID: 23467510)
21. Is there a role for thioguanine therapy in IBD in 2017 and beyond?
Taylor KM; Ward MG; Blaker PA; Sparrow MP
Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):473-486. PubMed ID: 28276819
[TBL] [Abstract][Full Text] [Related]
22. Thiopurines during pregnancy in inflammatory bowel disease: is there a risk for the (unborn) child?
de Boer NK; de Meij T; van Bodegraven AA
Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):669-71. PubMed ID: 24134152
[No Abstract] [Full Text] [Related]
23. Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.
Min MX; Weinberg DI; McCabe RP
J Clin Pharm Ther; 2014 Apr; 39(2):107-11. PubMed ID: 24438369
[TBL] [Abstract][Full Text] [Related]
24. Toxicity profile of thiopurines in inflammatory bowel disease: a retrospective cohort analysis.
Labidi A; Hafi M; Ben Mustapha N; Serghini M; Fekih M; Boubaker J
Tunis Med; 2020 May; 98(5):404-412. PubMed ID: 32548844
[TBL] [Abstract][Full Text] [Related]
25. Dosing 6-thioguanine in inflammatory bowel disease: expert-based guidelines for daily practice.
Seinen ML; van Asseldonk DP; Mulder CJ; de Boer NK
J Gastrointestin Liver Dis; 2010 Sep; 19(3):291-4. PubMed ID: 20922194
[TBL] [Abstract][Full Text] [Related]
26. Thiopurine therapy: when to start and when to stop.
McGovern DP; Travis SP
Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):219-23. PubMed ID: 12610314
[TBL] [Abstract][Full Text] [Related]
27. Small intestinal bacterial overgrowth in inactive Crohn's disease: influence of thiopurine and biological treatment.
Sánchez-Montes C; Ortiz V; Bastida G; Rodríguez E; Yago M; Beltrán B; Aguas M; Iborra M; Garrigues V; Ponce J; Nos P
World J Gastroenterol; 2014 Oct; 20(38):13999-4003. PubMed ID: 25320539
[TBL] [Abstract][Full Text] [Related]
28. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
Kiszka-Kanowitz M; Theede K; Nielsen AM
Ugeskr Laeger; 2014 May; 176(22):. PubMed ID: 25352005
[TBL] [Abstract][Full Text] [Related]
29. 6-Mercaptopurine for Azathioprine Intolerant Inflammatory Bowel Disease: Literature Search and Reappraisal of Own Data.
Actis GC; Pellicano R; Rosina F
Inflamm Allergy Drug Targets; 2015; 14(2):133-7. PubMed ID: 26728773
[TBL] [Abstract][Full Text] [Related]
30. Routine use of thiopurines in maintaining remission in pediatric Crohn's disease.
Boyle BM; Kappelman MD; Colletti RB; Baldassano RN; Milov DE; Crandall WV
World J Gastroenterol; 2014 Jul; 20(27):9185-90. PubMed ID: 25083093
[TBL] [Abstract][Full Text] [Related]
31. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
Kiszka-Kanowitz M; Theede K; Nielsen AM
Ugeskr Laeger; 2015 Jun; 177(26):1253-5. PubMed ID: 26550625
[TBL] [Abstract][Full Text] [Related]
32. Role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD.
Benkov K; Lu Y; Patel A; Rahhal R; Russell G; Teitelbaum J;
J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):333-40. PubMed ID: 23287804
[TBL] [Abstract][Full Text] [Related]
33. Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease.
Vasudevan A; Beswick L; Friedman AB; Moltzen A; Haridy J; Raghunath A; Sparrow M; van Langenberg D
Dig Liver Dis; 2018 Jul; 50(7):682-688. PubMed ID: 29525182
[TBL] [Abstract][Full Text] [Related]
34. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
Balram B; Lubov J; Theoret Y; Afif W; Bitton A; Wild G; Lakatos PL; Bessissow T
Dig Dis Sci; 2021 May; 66(5):1650-1657. PubMed ID: 32591969
[TBL] [Abstract][Full Text] [Related]
35. Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol.
Leong RW; Gearry RB; Sparrow MP
Expert Opin Drug Saf; 2008 Sep; 7(5):607-16. PubMed ID: 18759713
[TBL] [Abstract][Full Text] [Related]
36. Review article: the role of non-biological drugs in refractory inflammatory bowel disease.
Ng SC; Chan FK; Sung JJ
Aliment Pharmacol Ther; 2011 Feb; 33(4):417-27. PubMed ID: 21138457
[TBL] [Abstract][Full Text] [Related]
37. A Concise History of Thiopurines for Inflammatory Bowel Disease: From Anecdotal Reporting to Treat-to-Target Algorithms.
Actis GC; Pellicano R; Ribaldone DG
Rev Recent Clin Trials; 2019; 14(1):4-9. PubMed ID: 30198438
[TBL] [Abstract][Full Text] [Related]
38. Table: safety of drugs for IBD in pregnancy.
Med Lett Drugs Ther; 2018 Jul; 60(1550):e116. PubMed ID: 30036355
[No Abstract] [Full Text] [Related]
39. Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
Wall GC; Muktar H; Effken C; Mahajan PB
Pharmacotherapy; 2018 Feb; 38(2):259-270. PubMed ID: 29197117
[TBL] [Abstract][Full Text] [Related]
40. Thiopurine-induced pancreatitis in inflammatory bowel diseases.
Ledder O; Lemberg DA; Day AS
Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):399-403. PubMed ID: 25494551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
